Company page

Amicogen, Inc.

Amicogen, Inc. is a public company traded under the ticker 092040 in the Korean market. The company has a market capitalization of approximately 59.58 million USD. Amicogen focuses on biotechnology and related fields, contributing to advancements in health and medicine.

profile092040:KRXAI content: aiUpdated June 24, 2026/company/amicogen-inc/c-mvnzct4h
Amicogen, Inc. logo
Ticker
092040:KRX
Asset type
Stock
Market cap
$59.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
KRX
Currency
KRW